Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

The breast cancer stem cell (BCSC) hypotheses suggest that breast cancer is derived from a single tumor-initiating cell with stem-like properties, but the source of these cells is unclear. We previously observed that induction of an immune response against an epithelial breast cancer led in vivo to...

Descripción completa

Detalles Bibliográficos
Autores: Santisteban-Eslava, M. (Marta)|||/items/563d2cef-8a22-4110-97f4-8e16eac15419, Reiman, J.M. (Jennifer M.)|||/items/429b10fa-3b70-4ad7-a2fa-9ad48c110300, Asiedu, M.K. (Michael K.)|||/items/4c131ec4-56c9-4a6d-8643-8446231d3548, Behrens, M.D. (Marshall D.)|||/items/fbb13757-ec83-4ae3-a08a-59dfca11d93d, Nassar, A. (Aziza)|||/items/92cbd32d-7327-4a60-bc37-6c306df9d414, Kalli, K.R. (Kimberly R.)|||/items/e8854046-0ec3-43ce-8df6-ff89f4a91352, Haluska, P. (Paul)|||/items/2c2e0a2c-1cbf-4c8d-9e4c-2d3368ca5114, Ingle, J.N. (James N.)|||/items/d7cdceca-6cc0-4fc3-83e0-37bb20369cd9, Hartmann, L.C. (Lynn C.)|||/items/6105fd75-58d1-424b-b4ad-4c3fe8a411a3, Manjili, M.H. (Masoud H.)|||/items/fbd76136-bcab-4378-be8a-7cb8ef5f087d, Radisky, D.C. (Derek C.)|||/items/d32a50a1-179b-4136-b290-ff8a044cc938, Ferrone, S. (Soldano)|||/items/c7d87af0-c01e-4f02-8d2e-6f6facd9e2f0, Knutson, K.L. (Keith L.)|||/items/fa5d1fc5-473c-4a89-9581-569e78ee8d27
Tipo de recurso: artículo
Fecha de publicación:2009
País:España
Institución:Universidad de Navarra
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:inglés
OAI Identifier:oai:dadun.unav.edu:10171/36321
Acceso en línea:https://hdl.handle.net/10171/36321
Access Level:acceso abierto
Palabra clave:Mammary neoplasms
Epithelial cells
Antigens, CD24
Antigens, CD44
id ES_993b0eb60738cd76b4abffc3a3f0e147
oai_identifier_str oai:dadun.unav.edu:10171/36321
network_acronym_str ES
network_name_str España
repository_id_str
spelling Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cellsSantisteban-Eslava, M. (Marta)|||/items/563d2cef-8a22-4110-97f4-8e16eac15419Reiman, J.M. (Jennifer M.)|||/items/429b10fa-3b70-4ad7-a2fa-9ad48c110300Asiedu, M.K. (Michael K.)|||/items/4c131ec4-56c9-4a6d-8643-8446231d3548Behrens, M.D. (Marshall D.)|||/items/fbb13757-ec83-4ae3-a08a-59dfca11d93dNassar, A. (Aziza)|||/items/92cbd32d-7327-4a60-bc37-6c306df9d414Kalli, K.R. (Kimberly R.)|||/items/e8854046-0ec3-43ce-8df6-ff89f4a91352Haluska, P. (Paul)|||/items/2c2e0a2c-1cbf-4c8d-9e4c-2d3368ca5114Ingle, J.N. (James N.)|||/items/d7cdceca-6cc0-4fc3-83e0-37bb20369cd9Hartmann, L.C. (Lynn C.)|||/items/6105fd75-58d1-424b-b4ad-4c3fe8a411a3Manjili, M.H. (Masoud H.)|||/items/fbd76136-bcab-4378-be8a-7cb8ef5f087dRadisky, D.C. (Derek C.)|||/items/d32a50a1-179b-4136-b290-ff8a044cc938Ferrone, S. (Soldano)|||/items/c7d87af0-c01e-4f02-8d2e-6f6facd9e2f0Knutson, K.L. (Keith L.)|||/items/fa5d1fc5-473c-4a89-9581-569e78ee8d27Mammary neoplasmsEpithelial cellsAntigens, CD24Antigens, CD44The breast cancer stem cell (BCSC) hypotheses suggest that breast cancer is derived from a single tumor-initiating cell with stem-like properties, but the source of these cells is unclear. We previously observed that induction of an immune response against an epithelial breast cancer led in vivo to the T-cell-dependent outgrowth of a tumor, the cells of which had undergone epithelial to mesenchymal transition (EMT). The resulting mesenchymal tumor cells had a CD24(-/lo)CD44(+) phenotype, consistent with BCSCs. In the present study, we found that EMT was induced by CD8 T cells and the resulting tumors had characteristics of BCSCs, including potent tumorigenicity, ability to reestablish an epithelial tumor, and enhanced resistance to drugs and radiation. In contrast to the hierarchal cancer stem cell hypothesis, which suggests that breast cancer arises from the transformation of a resident tissue stem cell, our results show that EMT can produce the BCSC phenotype. These findings have several important implications related to disease progression and relapse.American Association for Cancer ResearchDadun. Depósito Académico Digital Universidad de Navarra20142014-08-1220092009-04-0120092009-04-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10171/36321reponame:Dadun. Depósito Académico Digital de la Universidad de Navarrainstname:Universidad de NavarraInglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:dadun.unav.edu:10171/363212026-06-21T12:47:57Z
dc.title.none.fl_str_mv Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells
title Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells
spellingShingle Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells
Santisteban-Eslava, M. (Marta)|||/items/563d2cef-8a22-4110-97f4-8e16eac15419
Mammary neoplasms
Epithelial cells
Antigens, CD24
Antigens, CD44
title_short Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells
title_full Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells
title_fullStr Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells
title_full_unstemmed Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells
title_sort Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells
dc.creator.none.fl_str_mv Santisteban-Eslava, M. (Marta)|||/items/563d2cef-8a22-4110-97f4-8e16eac15419
Reiman, J.M. (Jennifer M.)|||/items/429b10fa-3b70-4ad7-a2fa-9ad48c110300
Asiedu, M.K. (Michael K.)|||/items/4c131ec4-56c9-4a6d-8643-8446231d3548
Behrens, M.D. (Marshall D.)|||/items/fbb13757-ec83-4ae3-a08a-59dfca11d93d
Nassar, A. (Aziza)|||/items/92cbd32d-7327-4a60-bc37-6c306df9d414
Kalli, K.R. (Kimberly R.)|||/items/e8854046-0ec3-43ce-8df6-ff89f4a91352
Haluska, P. (Paul)|||/items/2c2e0a2c-1cbf-4c8d-9e4c-2d3368ca5114
Ingle, J.N. (James N.)|||/items/d7cdceca-6cc0-4fc3-83e0-37bb20369cd9
Hartmann, L.C. (Lynn C.)|||/items/6105fd75-58d1-424b-b4ad-4c3fe8a411a3
Manjili, M.H. (Masoud H.)|||/items/fbd76136-bcab-4378-be8a-7cb8ef5f087d
Radisky, D.C. (Derek C.)|||/items/d32a50a1-179b-4136-b290-ff8a044cc938
Ferrone, S. (Soldano)|||/items/c7d87af0-c01e-4f02-8d2e-6f6facd9e2f0
Knutson, K.L. (Keith L.)|||/items/fa5d1fc5-473c-4a89-9581-569e78ee8d27
author Santisteban-Eslava, M. (Marta)|||/items/563d2cef-8a22-4110-97f4-8e16eac15419
author_facet Santisteban-Eslava, M. (Marta)|||/items/563d2cef-8a22-4110-97f4-8e16eac15419
Reiman, J.M. (Jennifer M.)|||/items/429b10fa-3b70-4ad7-a2fa-9ad48c110300
Asiedu, M.K. (Michael K.)|||/items/4c131ec4-56c9-4a6d-8643-8446231d3548
Behrens, M.D. (Marshall D.)|||/items/fbb13757-ec83-4ae3-a08a-59dfca11d93d
Nassar, A. (Aziza)|||/items/92cbd32d-7327-4a60-bc37-6c306df9d414
Kalli, K.R. (Kimberly R.)|||/items/e8854046-0ec3-43ce-8df6-ff89f4a91352
Haluska, P. (Paul)|||/items/2c2e0a2c-1cbf-4c8d-9e4c-2d3368ca5114
Ingle, J.N. (James N.)|||/items/d7cdceca-6cc0-4fc3-83e0-37bb20369cd9
Hartmann, L.C. (Lynn C.)|||/items/6105fd75-58d1-424b-b4ad-4c3fe8a411a3
Manjili, M.H. (Masoud H.)|||/items/fbd76136-bcab-4378-be8a-7cb8ef5f087d
Radisky, D.C. (Derek C.)|||/items/d32a50a1-179b-4136-b290-ff8a044cc938
Ferrone, S. (Soldano)|||/items/c7d87af0-c01e-4f02-8d2e-6f6facd9e2f0
Knutson, K.L. (Keith L.)|||/items/fa5d1fc5-473c-4a89-9581-569e78ee8d27
author_role author
author2 Reiman, J.M. (Jennifer M.)|||/items/429b10fa-3b70-4ad7-a2fa-9ad48c110300
Asiedu, M.K. (Michael K.)|||/items/4c131ec4-56c9-4a6d-8643-8446231d3548
Behrens, M.D. (Marshall D.)|||/items/fbb13757-ec83-4ae3-a08a-59dfca11d93d
Nassar, A. (Aziza)|||/items/92cbd32d-7327-4a60-bc37-6c306df9d414
Kalli, K.R. (Kimberly R.)|||/items/e8854046-0ec3-43ce-8df6-ff89f4a91352
Haluska, P. (Paul)|||/items/2c2e0a2c-1cbf-4c8d-9e4c-2d3368ca5114
Ingle, J.N. (James N.)|||/items/d7cdceca-6cc0-4fc3-83e0-37bb20369cd9
Hartmann, L.C. (Lynn C.)|||/items/6105fd75-58d1-424b-b4ad-4c3fe8a411a3
Manjili, M.H. (Masoud H.)|||/items/fbd76136-bcab-4378-be8a-7cb8ef5f087d
Radisky, D.C. (Derek C.)|||/items/d32a50a1-179b-4136-b290-ff8a044cc938
Ferrone, S. (Soldano)|||/items/c7d87af0-c01e-4f02-8d2e-6f6facd9e2f0
Knutson, K.L. (Keith L.)|||/items/fa5d1fc5-473c-4a89-9581-569e78ee8d27
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Dadun. Depósito Académico Digital Universidad de Navarra
dc.subject.none.fl_str_mv Mammary neoplasms
Epithelial cells
Antigens, CD24
Antigens, CD44
topic Mammary neoplasms
Epithelial cells
Antigens, CD24
Antigens, CD44
description The breast cancer stem cell (BCSC) hypotheses suggest that breast cancer is derived from a single tumor-initiating cell with stem-like properties, but the source of these cells is unclear. We previously observed that induction of an immune response against an epithelial breast cancer led in vivo to the T-cell-dependent outgrowth of a tumor, the cells of which had undergone epithelial to mesenchymal transition (EMT). The resulting mesenchymal tumor cells had a CD24(-/lo)CD44(+) phenotype, consistent with BCSCs. In the present study, we found that EMT was induced by CD8 T cells and the resulting tumors had characteristics of BCSCs, including potent tumorigenicity, ability to reestablish an epithelial tumor, and enhanced resistance to drugs and radiation. In contrast to the hierarchal cancer stem cell hypothesis, which suggests that breast cancer arises from the transformation of a resident tissue stem cell, our results show that EMT can produce the BCSC phenotype. These findings have several important implications related to disease progression and relapse.
publishDate 2009
dc.date.none.fl_str_mv 2009
2009-04-01
2009
2009-04-01
2014
2014-08-12
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/10171/36321
url https://hdl.handle.net/10171/36321
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv American Association for Cancer Research
publisher.none.fl_str_mv American Association for Cancer Research
dc.source.none.fl_str_mv reponame:Dadun. Depósito Académico Digital de la Universidad de Navarra
instname:Universidad de Navarra
instname_str Universidad de Navarra
reponame_str Dadun. Depósito Académico Digital de la Universidad de Navarra
collection Dadun. Depósito Académico Digital de la Universidad de Navarra
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869414256953262080
score 15.300719